ISSCR News
The ISSCR’s VISION2030 Gathers Global Leaders in Stem Cell Research and Regenerative Medicine to Chart the Next Decade of Breakthroughs
Biotech business innovators and scientific trailblazers converge for a must attend future-forward event 7-8 January 2021
Skokie, IL – The ISSCR’s VISION2030: A Forecast for the Field is bringing together biotech CEOs who have successfully transformed scientific breakthroughs into thriving businesses that are improving human health. Join us for in-depth executive interviews that explore the next decade for the field on 7-8 January 2021. The event comes at a pivotal moment in regenerative medicine and stem cell science as discovery, translation, and investment intersect. Register and see the full program.
The ISSCR Releases Informed Consent Standard for Stem Cell-based Interventions
12 August 2019 -- The International Society for Stem Cell Research (ISSCR) today released a professional standard of informed consent for stem cell-based interventions performed outside of formal clinical trials, such as the unapproved and unproven “treatments” offered by clinicians at direct-to-consumer clinics. The standard is meant to help ensure that patients are informed about the potential benefits and risks of stem cell-based medical interventions, and was developed with input from clinicians, ethicists, researchers, and regulators from around the world.
Hans Clevers Becomes President of the ISSCR
The International Society for Stem Cell Research (ISSCR) is pleased to announce Hans Clevers, Hubrecht Institute, the Netherlands, as the incoming president of the ISSCR and its board of directors. Clevers assumes the post immediately following the 15th ISSCR Annual Meeting in Boston, 14-17 June, 2017.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .